“Boadicea was the name of a British soldier who fought the Roman invasion. Now is also the name of a new tool to combat the new enemy: cancer.” The researcher of the University of Cambridge, Antonis Antoniou, explained at the IDIBELL seminar on 30 September his latest advances in the development of genetic models, such […]
The Director of the Cancer Epigenetics and Biology program of IDIBELL, Manel Esteller has been awarded the 2011 European Association for Cancer Research (EACR) Cancer Researcher Award Lecture.
The Instituto de Salud Carlos III has issued a preliminary determination of the grant program in Health Research Projects of the Health Research Fund (FIS), corresponding to the call of 2011. The 27 IDIBELL selected projects will receive three million 400 000 Euros over the next four years.
The Spanish Health Research Fund will finance 27 IDIBELL research projects Read More »
The “Imprinting and Beyond: Monoallelic expression in Health and Disease” conference, hosted by David Monk (PEBC-IDIBELL) and Robert Feil (CNRS-Montpellier, France) was held on the 21st-23rd September at Institut d’Estudis Catalans. Institut d’Estudis Catalans
The awarded scientifics are the IDIBELL researcher, Manel Esteller, and the professor of genetics at the University of Seville, Enrique Cerdà, in the categories of applications to genetics and basic genetics, respectively.
Manel Esteller receives the National Genetics Award Read More »
In order to answer these ambitious questions, Andrew Plestan focuses his research on one of the pieces involved in these processes: the glutamate receptors. “By understanding how they work, we understand the neural connections and how the brain processes and stores information.” Plested has explained his progress in a session within the IDIBELL seminar series on September 16th.
Outstanding experts in bioinformatics, systems biology and regulatory genomics from around the world will meet from 14 to 19 October at IDIBELL to discuss the latest developments in these fields. DREAM ENGINEERING CHALLENGES President: Gustavo Stolovitzky CANCER CONFERENCE ON RICCI Informatics President: Miguel Angel Pujana RECOMB Systems Biology President: Andrea Califano RECOMB REGULATORY GENOMICS President: Manolis Kells
A molecule very similar to glucose kills ‘in vitro’ tumor cells of alveolar rhabdomyosarcoma New therapeutic strategies Article’s reference
The new course begins in IDIBELL with the resumption of external seminars. As always, the sessions take place on Friday at one pm in the auditorium of the Duran Reynals Hospital (ICO), the Bellvitge University Hospital and the Bellvitge Campus of the University of Barcelona. More information
The course begins at IDIBELL Read More »
The study involved more than 20 000 women from different countries Intrauterine devices (IUDs) may protect against cervical cancer. This is the conclusion of the broadest epidemiological study to date in which has participated the research group in Viruses and Cancer of IDIBELL, published at The Lancet Oncology. Reduces the risk by half Article’s reference
IUD reduces by half the risk of cervical cancer Read More »
